Figure S7. (A). Knockdown of circNRIP1 and miR-149-5p significantly reversed the expression levels of AKT1/mTOR pathway molecules, certain metabolism markers and EMT markers achieved by knocking down only circNRIP1 in BGC-823 cells. (B). We observed that the reduction of GC cell proliferation mediated by circNRIP1 knockdown was successfully blocked by miR-149-5p inhibition in BGC-823 cells, scale bar = 100 µm. (C). We observed that the reduction of metastasis of GC cells mediated by circNRIP1 knockdown was successfully blocked by miR-149-5p inhibition in BGC-823 cells, scale bar = 100 µm. All data are presented as the mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001. (TIF 3849 kb
Figure S1. The cutoff value of circDLST divided the GC patients into circDLST high and low expressio...
Figure S5. miR-200b-3p promotes TGF-β-induced EMT and invasion in NSCLC cells. (A) After being serum...
Table S1. The primer sequences. Table S2. Correlation of circDLST expression with clinicopathologic ...
Figure S1. (A). We verified the significantly upregulated pull-down efficiency of the circNRIP1 prob...
Figure S2. (A). We used qRT-PCR to verify the circNRIP1 silencing efficiency and rule out the possib...
Figure S5. (A). Potential binding between circNRIP1 and miR-149-5p based on their complementary sequ...
Figure S9. (A). We observed that only the wild-type plasmid (#4), and neither the I1QB nor I3QB dele...
Figure S3. (A). We performed a series of glycolysis detection experiments. We found that knockdown o...
Figure S1. (a) A total of 6 circRNAs based on the multiple fold difference in circRNA microarray and...
Figure S8. (A). We used a transmission electron microscope (TEM) to determine the existence and morp...
Figure S4. (A). A cluster heat map was used to show the expression variations of these circRNA trans...
Figure S1. a, The expression levels of circYAP1 in GC patients with TS âĽ5 cm or <5 cm. b, Receiv...
Figure S5. TCGA analysis of the expression levels of miR-193b-5p, miR-542-3p, miR-362-5p and miR-203...
Figure S6. TCGA analysis of the association of high or low miR-502-5p expression with the overall su...
Background: CircRNA has emerged as a new non-coding RNA that plays crucial roles in tumour initiatio...
Figure S1. The cutoff value of circDLST divided the GC patients into circDLST high and low expressio...
Figure S5. miR-200b-3p promotes TGF-β-induced EMT and invasion in NSCLC cells. (A) After being serum...
Table S1. The primer sequences. Table S2. Correlation of circDLST expression with clinicopathologic ...
Figure S1. (A). We verified the significantly upregulated pull-down efficiency of the circNRIP1 prob...
Figure S2. (A). We used qRT-PCR to verify the circNRIP1 silencing efficiency and rule out the possib...
Figure S5. (A). Potential binding between circNRIP1 and miR-149-5p based on their complementary sequ...
Figure S9. (A). We observed that only the wild-type plasmid (#4), and neither the I1QB nor I3QB dele...
Figure S3. (A). We performed a series of glycolysis detection experiments. We found that knockdown o...
Figure S1. (a) A total of 6 circRNAs based on the multiple fold difference in circRNA microarray and...
Figure S8. (A). We used a transmission electron microscope (TEM) to determine the existence and morp...
Figure S4. (A). A cluster heat map was used to show the expression variations of these circRNA trans...
Figure S1. a, The expression levels of circYAP1 in GC patients with TS âĽ5 cm or <5 cm. b, Receiv...
Figure S5. TCGA analysis of the expression levels of miR-193b-5p, miR-542-3p, miR-362-5p and miR-203...
Figure S6. TCGA analysis of the association of high or low miR-502-5p expression with the overall su...
Background: CircRNA has emerged as a new non-coding RNA that plays crucial roles in tumour initiatio...
Figure S1. The cutoff value of circDLST divided the GC patients into circDLST high and low expressio...
Figure S5. miR-200b-3p promotes TGF-β-induced EMT and invasion in NSCLC cells. (A) After being serum...
Table S1. The primer sequences. Table S2. Correlation of circDLST expression with clinicopathologic ...